Breast cancer in low and middle income countries (LMICs): A shifting tide in global health

Breast Journal

Volumn 21, Issue 1, 2015, Pages 111-118

  Anderson, Benjamin O ^a   Ilbawi, André M ^b   El Saghir, Nagi S ^c  

^a USA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

global breast cancer control; implementation science; national cancer plan; resource stratified guideline

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CLINICAL EVALUATION; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HEALTH; HUMAN; LOW AND MIDDLE INCOME COUNTRY; PRACTICE GUIDELINE; SOCIAL STATUS; BREAST NEOPLASMS; DEVELOPING COUNTRY; ECONOMICS; FEMALE; HEALTH CARE DELIVERY;

BREAST NEOPLASMS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; GLOBAL HEALTH; GUIDELINE ADHERENCE; HUMANS;

EID: 84920813934     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12357     Document Type: Article

References (46)

1. Lozano R, Naghavi M, Foreman K, et al,. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
2. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases (A/RES/66/2). United Nations General Assembly; September 19, 2011; New York, NY: United Nations, 2012.
3. Knaul FM, Adami H-O, Adebamowo C, et al,. The global cancer divide: an equity imperative (chapter 2). In:, Knaul FM, Gralow JR, Atun R, Bhadelia A, eds. Closing the Global Cancer Divide: An Equity Imperative. Boston, MA: Harvard University Press, 2012: 29-70.
4. Ferlay J, Soerjomataram I, Ervik M, et al,. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. 2014; Availale at: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx (accessed February 2014).
5. Farmer P, Frenk J, Knaul FM, et al,. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 376: 1186-93.
6. Kingham TP, Alatise OI, Vanderpuye V, et al,. Treatment of cancer in sub-Saharan Africa. Lancet Oncol 2013; 14: e158-67.
7. Nugent RA, Feigl AB,. Where have all the donors gone? Scarce donor funding for non-communicable diseases (working paper 228). Washington, DC: Center for Global Development, 2010.
8. El Saghir N, Farhat R, Charara R, Khoury K,. Enhancing cancer care in areas of limited resources: our next steps. Future Oncol 2014; 10: 1953-65.
9. Vineis P, Wild CP,. Global cancer patterns: causes and prevention. Lancet 2014; 383: 549-57.
10. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M, Comparative Risk Assessment Collaborating Group. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366: 1784-93.
11. Alwan A,. Global status report on noncommunicable diseases 2010: executive summary. Geneva: World Health Organization, 2011.
12. Tsu VD, Jeronimo J, Anderson BO,. Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ 2013; 91: 683-90.
13. Desantis C, Ma J, Bryan L, Jemal A,. Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64: 52-62.
14. IARC. Breast cancer screening. In:, Vainio H, Bianchini F, eds. International Agency for Research on Cancer (IARC) Handbooks of Cancer Prevention. Lyon, France: IARC Press; 2002: 87-117.
15. Parkin DM, Fernandez LM,. Use of statistics to assess the global burden of breast cancer. Breast J 2006; 12 (Suppl 1): S70-80.
16. Forouzanfar MH, Foreman KJ, Delossantos AM, et al,. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011; 378: 1461-84.
17. Hisham AN, Yip CH,. Spectrum of breast cancer in Malaysian women: overview. World J Surg 2003; 27: 921-3.
18. Berry DA, Cronin KA, Plevritis SK, et al,. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784-92.
19. Sloan F, Gelband H,. Cancer control opportunities in low- and middle-income countries. Committee on Cancer Control in Low- and Middle-Income Countries. Washington, DC: National Academies Press, 2007.
20. Yip CH, Smith RA, Anderson BO, et al,. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 2008; 113 (8 Suppl): 2244-56.
21. Shyyan R, Sener SF, Anderson BO, et al,. Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer 2008; 113 (8 Suppl): 2257-68.
22. Eniu A, Carlson RW, El Saghir NS, et al,. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer 2008; 113 (8 Suppl): 2269-81.
23. Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, et al. Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast. 2011; 20 (2 Suppl): S20-9.
24. Anderson BO, Yip CH, Smith RA, et al,. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008; 113 (8 Suppl): 2221-43.
25. Anderson BO, Cazap E, El Saghir NS, et al,. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011; 12: 387-98.
26. Masood S, Vass L, Ibarra JA Jr, et al,. Breast pathology guideline implementation in low- and middle-income countries. Cancer 2008; 113 (8 Suppl): 2297-304.
27. El Saghir NS, Eniu A, Carlson RW, Aziz Z, Vorobiof D, Hortobagyi GN,. Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries. Cancer 2008; 113 (8 suppl): 2315-54.
28. Bese NS, Munshi A, Budrukkar A, Elzawawy A, Perez CA,. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer 2008; 113 (8 suppl): 2305-14.
29. Cardoso F, Bese N, Distelhorst SR, et al,. Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22: 593-605.
30. Ganz PA, Yip CH, Gralow JR, et al,. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22: 606-15.
31. Cleary J, Ddungu H, Distelhorst SR, et al,. Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22: 616-27.
32. Echavarria MI, Anderson BO, Duggan C, Thompson B,. Breast health global initiative (BHGI) guidelines for breast cancer in low and middle-income countries: a systematic examination of the literature to determine global guideline uptake. Lancet Oncol, in press.
33. Beaglehole R, Bonita R, Magnusson R,. Global cancer prevention: an important pathway to global health and development. Public Health 2011; 125: 821-31.
34. Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R, International Cancer Screening Network. Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen 2010; 17: 139-46.
35. Jemal A, Bray F, Forman D, et al,. Cancer burden in Africa and opportunities for prevention. Cancer 2012; 118: 4372-84.
36. Thomas DB, Murillo RH, Kardinah D, Anderson BO,. Breast cancer early detection and clinical guidelines (chapter 21). In:, Soliman AS, Schottenfeld D, Boffetta P, eds. Cancer Epidemiology: Low and Middle Income Countries and Special Populations. New York: Oxford University Press, 2013: 378-95.
37. El Saghir N, Charara RN,. International screening and early detection of breast cancer: resource-sensitive, age- and risk-specific guidelines. Breast Cancer Management 2014; in press.
38. Carlson RW, Allred DC, Anderson BO, et al,. Invasive breast cancer. J Natl Compr Canc Netw 2011; 9: 136-222.
39. Thorat MA, Rangole A, Nadkarni MS, Parmar V, Badwe RA,. Revision surgery for breast cancer: single-institution experience. Cancer 2008; 113 (8 Suppl): 2347-52.
40. Humphrey LL, Helfand M, Chan BK, Woolf SH,. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137 (5 Part 1): 347-60.
41. Wong IO, Cowling BJ, Schooling CM, Leung GM,. Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population. Int J Cancer 2007; 121: 1556-63.
42. Chia KS, Reilly M, Tan CS, et al,. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 2005; 113: 302-6.
43. Azaiza F, Cohen M, Awad M, Daoud F,. Factors associated with low screening for breast cancer in the Palestinian Authority: relations of availability, environmental barriers and cancer-related fatalism. Cancer 2010; 116: 4646-55.
44. Ashbury FD, Cameron C, Mercer SL, Fitch M, Nielsen E,. One-on-one peer support and quality of life for breast cancer patients. Patient Educ Couns 1998; 35: 89-100.
45. Visco F,. The National Breast Cancer Coalition: setting the standard for advocate collaboration in clinical trials. Cancer Treat Res 2007; 132: 143-56.
46. Schmidt C,. Komen/ASCO program aims to swell ranks of minority oncologists. J Natl Cancer Inst 2009; 101: 224-5, 7.